Start-up Illumigen Biosciences Develops New Genome Analysis Platform | GenomeWeb

NEW YORK, Feb 1 – Illumigen Biosciences, a start-up applied genomics company in Seattle, Wash., has unveiled a new computing platform for analyzing the human genome, the company said Thursday.

The system, GeneLamp, compares experimental data from Illumigen’s in-house laboratories with data from “a variety” of genomics databases to search for drug targets, according to the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."